An online survival tool (https://kmplot.com/analysis/), which integrates published RNA-seq datasets, revealed a significant association between high GFPT1 expression and reduced overall survival (OS) and progression-free survival (PFS) specifically in breast cancer patients (Figure 2A) (Lanczky and Gyorffy, 2021). Here, GFPT1 is linked to breast carcinoma.